etilefrine has been researched along with Esophageal Neoplasms in 3 studies
Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " When the amount of pleural effusion decreased to <50 mL/day, we performed pleurodesis with Picibanil (OK432)." | 7.81 | New Combined Medical Treatment With Etilefrine and Octreotide for Chylothorax After Esophagectomy: A Case Report and Review of the Literature. ( Haruta, S; Iizuka, T; Ohkura, Y; Tanaka, T; Udagawa, H; Ueno, M, 2015) |
| "Post-operative chylothorax and chyloperitoneum resulting from a thoracic duct injury are possible complications of esophagectomy for carcinoma." | 5.30 | Successful management of post-esophagectomy chylothorax/chyloperitoneum by etilefrine. ( Billeret, V; Guillem, P; Houcke, ML; Triboulet, JP, 1999) |
| " When the amount of pleural effusion decreased to <50 mL/day, we performed pleurodesis with Picibanil (OK432)." | 3.81 | New Combined Medical Treatment With Etilefrine and Octreotide for Chylothorax After Esophagectomy: A Case Report and Review of the Literature. ( Haruta, S; Iizuka, T; Ohkura, Y; Tanaka, T; Udagawa, H; Ueno, M, 2015) |
| "Their initial illnesses were a right pulmonary hydatid cyst associated with hepatic disease, a tumour of the posterior mediastinum, an oesophageal carcinoma and metastases in the left lung." | 1.33 | [Management of postoperative chylothorax]. ( Baccari, S; Djilani, H; Hantous, T; Kilani, T; Marghli, A; Mestiri, T; Sadok Boudaya, M; Smati, B, 2006) |
| "Post-operative chylothorax and chyloperitoneum resulting from a thoracic duct injury are possible complications of esophagectomy for carcinoma." | 1.30 | Successful management of post-esophagectomy chylothorax/chyloperitoneum by etilefrine. ( Billeret, V; Guillem, P; Houcke, ML; Triboulet, JP, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohkura, Y | 1 |
| Ueno, M | 1 |
| Iizuka, T | 1 |
| Haruta, S | 1 |
| Tanaka, T | 1 |
| Udagawa, H | 1 |
| Smati, B | 1 |
| Sadok Boudaya, M | 1 |
| Marghli, A | 1 |
| Mestiri, T | 1 |
| Baccari, S | 1 |
| Hantous, T | 1 |
| Djilani, H | 1 |
| Kilani, T | 1 |
| Guillem, P | 1 |
| Billeret, V | 1 |
| Houcke, ML | 1 |
| Triboulet, JP | 1 |
3 other studies available for etilefrine and Esophageal Neoplasms
| Article | Year |
|---|---|
New Combined Medical Treatment With Etilefrine and Octreotide for Chylothorax After Esophagectomy: A Case Report and Review of the Literature.
Topics: Adult; Antineoplastic Agents; Chylothorax; Drug Therapy, Combination; Esophageal Neoplasms; Esophage | 2015 |
[Management of postoperative chylothorax].
Topics: Adolescent; Adrenergic Agonists; Adult; Carcinoma, Squamous Cell; Case Management; Chylothorax; Comb | 2006 |
Successful management of post-esophagectomy chylothorax/chyloperitoneum by etilefrine.
Topics: Adult; Aged; Chylothorax; Chylous Ascites; Esophageal Neoplasms; Esophagectomy; Etilefrine; Humans; | 1999 |